Status:
COMPLETED
Football Fitness After Breast Cancer
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
University of Southern Denmark
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Late effects of breast cancer treatment are widely reported including deteriorating fitness, fatigue, loss of muscle and bone mass, and increased body fat percentage. Exercise interventions may amelio...
Eligibility Criteria
Inclusion
- Women surgically managed for breast cancer, local and regional advanced breast cancer.
- Completion of adjuvant chemotherapy and radiation therapy.
- Legally competent persons with ability to read and understand Danish.
- Signed informed consent.
- Performance level 0-1 (WHO).
Exclusion
- WHO performance level \> 1.
- Osteoporosis (T-score \< -2.5).
- Known metastatic breast cancer (stage IV).
- Women in DBCG-group I (age =\> 60 years, tumor =\< 10 mm, invasive ductal carcinoma grade I, invasive lobular carcinoma grade I / II, estrogen receptor positive and HER2 normal).
- Cardiovascular or pulmonary disorders (e.g., arrhythmias, ischemic heart disease, unregulated high blood pressure, chronic obstructive lung disease).
- Ongoing anticoagulant therapy (vitamin K antagonists; Marevan, Marcoumar and low molecular weight heparins; Innohep, Clexane, Fragmin) for pulmonary embolism or deep venous thrombosis (DVT) due to increased bleeding risk of falls and clashes with other players during exercise.
- Current or scheduled chemotherapy and radiation therapy in the intervention period (12 months).
Key Trial Info
Start Date :
March 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03284567
Start Date
March 20 2017
End Date
January 20 2020
Last Update
October 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Copenhagen, Rigshospitalet
Copenhagen, Denmark, 2100